nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CES1—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0607	0.0671	CbGpPWpGaD
Rufinamide—GRM5—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0599	0.0662	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0381	0.0421	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0341	0.0376	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—RRM1—adrenal gland cancer	0.0322	0.0356	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0228	0.0252	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0204	0.0226	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0192	0.0212	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NR5A1—adrenal gland cancer	0.0136	0.0151	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NR5A1—adrenal gland cancer	0.0122	0.0134	CbGpPWpGaD
Rufinamide—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.012	0.0132	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0115	0.0127	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NR5A1—adrenal gland cancer	0.0111	0.0123	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0109	0.012	CbGpPWpGaD
Rufinamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0108	0.0119	CbGpPWpGaD
Rufinamide—CYP2E1—urine—adrenal gland cancer	0.0105	0.11	CbGeAlD
Rufinamide—GRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.0103	0.0113	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00986	0.0109	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—RB1—adrenal gland cancer	0.00927	0.0102	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NR5A1—adrenal gland cancer	0.00899	0.00994	CbGpPWpGaD
Rufinamide—SCN7A—cardiac atrium—adrenal gland cancer	0.00897	0.0942	CbGeAlD
Rufinamide—SCN3A—Developmental Biology—NR5A1—adrenal gland cancer	0.0086	0.00951	CbGpPWpGaD
Rufinamide—CES1—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00856	0.00946	CbGpPWpGaD
Rufinamide—CYP3A4—urine—adrenal gland cancer	0.00845	0.0888	CbGeAlD
Rufinamide—SCN4A—Developmental Biology—NR5A1—adrenal gland cancer	0.00826	0.00913	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NR5A1—adrenal gland cancer	0.00826	0.00913	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MED12—adrenal gland cancer	0.0082	0.00906	CbGpPWpGaD
Rufinamide—CES1—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.00815	0.009	CbGpPWpGaD
Rufinamide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.00804	0.00888	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NR5A1—adrenal gland cancer	0.00797	0.00881	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NR5A1—adrenal gland cancer	0.00797	0.00881	CbGpPWpGaD
Rufinamide—SCN7A—adrenal gland—adrenal gland cancer	0.00782	0.0822	CbGeAlD
Rufinamide—SCN11A—Developmental Biology—MED12—adrenal gland cancer	0.00731	0.00807	CbGpPWpGaD
Rufinamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00729	0.00806	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—CDC42—adrenal gland cancer	0.00711	0.00786	CbGpPWpGaD
Rufinamide—SCN9A—pituitary gland—adrenal gland cancer	0.00686	0.0721	CbGeAlD
Rufinamide—SCN7A—L1CAM interactions—EGFR—adrenal gland cancer	0.00684	0.00756	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MED12—adrenal gland cancer	0.00668	0.00739	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0065	0.00719	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—CDC42—adrenal gland cancer	0.00634	0.007	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00618	0.00683	CbGpPWpGaD
Rufinamide—SCN9A—adrenal gland—adrenal gland cancer	0.00613	0.0644	CbGeAlD
Rufinamide—SCN4A—pituitary gland—adrenal gland cancer	0.00612	0.0643	CbGeAlD
Rufinamide—SCN11A—L1CAM interactions—EGFR—adrenal gland cancer	0.0061	0.00674	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00597	0.00659	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00591	0.00653	CbGpPWpGaD
Rufinamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00589	0.00651	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00582	0.00644	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0058	0.00641	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—CDC42—adrenal gland cancer	0.00579	0.0064	CbGpPWpGaD
Rufinamide—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00579	0.0064	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.0056	0.00619	CbGpPWpGaD
Rufinamide—SCN8A—L1CAM interactions—EGFR—adrenal gland cancer	0.00558	0.00616	CbGpPWpGaD
Rufinamide—SCN4A—adrenal gland—adrenal gland cancer	0.00547	0.0575	CbGeAlD
Rufinamide—SCN2A—pituitary gland—adrenal gland cancer	0.00542	0.0569	CbGeAlD
Rufinamide—GRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00541	0.00598	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MED12—adrenal gland cancer	0.0054	0.00597	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00526	0.00582	CbGpPWpGaD
Rufinamide—SCN10A—pituitary gland—adrenal gland cancer	0.00522	0.0549	CbGeAlD
Rufinamide—SCN3A—Developmental Biology—MED12—adrenal gland cancer	0.00517	0.00571	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00509	0.00562	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CDC42—adrenal gland cancer	0.00507	0.00561	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MED12—adrenal gland cancer	0.00497	0.00549	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MED12—adrenal gland cancer	0.00497	0.00549	CbGpPWpGaD
Rufinamide—CES1—adrenal gland—adrenal gland cancer	0.00488	0.0513	CbGeAlD
Rufinamide—SCN5A—cardiac atrium—adrenal gland cancer	0.00486	0.0511	CbGeAlD
Rufinamide—SCN10A—Developmental Biology—MED12—adrenal gland cancer	0.00479	0.00529	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MED12—adrenal gland cancer	0.00479	0.00529	CbGpPWpGaD
Rufinamide—SCN3A—pituitary gland—adrenal gland cancer	0.00476	0.05	CbGeAlD
Rufinamide—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.00471	0.0052	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CDC42—adrenal gland cancer	0.00469	0.00518	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CDC42—adrenal gland cancer	0.00452	0.005	CbGpPWpGaD
Rufinamide—SCN9A—L1CAM interactions—EGFR—adrenal gland cancer	0.00451	0.00499	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00449	0.00496	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CDC42—adrenal gland cancer	0.00448	0.00495	CbGpPWpGaD
Rufinamide—SCN3A—L1CAM interactions—EGFR—adrenal gland cancer	0.00431	0.00477	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—CDC42—adrenal gland cancer	0.00431	0.00476	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CDC42—adrenal gland cancer	0.00431	0.00476	CbGpPWpGaD
Rufinamide—SCN3A—adrenal gland—adrenal gland cancer	0.00425	0.0447	CbGeAlD
Rufinamide—SCN1A—Axon guidance—CDC42—adrenal gland cancer	0.00415	0.00459	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CDC42—adrenal gland cancer	0.00415	0.00459	CbGpPWpGaD
Rufinamide—SCN4A—L1CAM interactions—EGFR—adrenal gland cancer	0.00415	0.00458	CbGpPWpGaD
Rufinamide—SCN2A—L1CAM interactions—EGFR—adrenal gland cancer	0.00415	0.00458	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CDC42—adrenal gland cancer	0.00414	0.00457	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00403	0.00445	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00402	0.00444	CbGpPWpGaD
Rufinamide—SCN10A—L1CAM interactions—EGFR—adrenal gland cancer	0.004	0.00442	CbGpPWpGaD
Rufinamide—SCN1A—L1CAM interactions—EGFR—adrenal gland cancer	0.004	0.00442	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00378	0.00417	CbGpPWpGaD
Rufinamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00355	0.00393	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00353	0.0039	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00349	0.00386	CbGpPWpGaD
Rufinamide—ALB—adrenal gland—adrenal gland cancer	0.00339	0.0357	CbGeAlD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00338	0.00374	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00337	0.00373	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00337	0.00372	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CDC42—adrenal gland cancer	0.00334	0.0037	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.00325	0.00359	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.0032	0.00354	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CDC42—adrenal gland cancer	0.0032	0.00354	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00319	0.00353	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00318	0.00351	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00311	0.00344	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.0031	0.00342	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CDC42—adrenal gland cancer	0.00307	0.0034	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CDC42—adrenal gland cancer	0.00307	0.0034	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00306	0.00338	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CDC42—adrenal gland cancer	0.00296	0.00328	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CDC42—adrenal gland cancer	0.00296	0.00328	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00292	0.00323	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00292	0.00323	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.00281	0.00311	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—EGFR—adrenal gland cancer	0.00259	0.00286	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00258	0.00285	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00241	0.00266	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00233	0.00257	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—EGFR—adrenal gland cancer	0.0023	0.00255	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00227	0.00251	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00223	0.00247	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—EGFR—adrenal gland cancer	0.00211	0.00233	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00209	0.00231	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.00208	0.0023	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00208	0.00229	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.00206	0.00228	CbGpPWpGaD
Rufinamide—CYP2E1—adrenal gland—adrenal gland cancer	0.00201	0.0211	CbGeAlD
Rufinamide—SCN8A—Developmental Biology—CTNNB1—adrenal gland cancer	0.0019	0.0021	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.00189	0.00209	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EGFR—adrenal gland cancer	0.00185	0.00204	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.00182	0.00202	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.00181	0.002	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00176	0.00195	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—adrenal gland cancer	0.0017	0.00188	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—adrenal gland cancer	0.00164	0.00182	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—adrenal gland cancer	0.00163	0.0018	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.0016	0.00177	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—adrenal gland cancer	0.00157	0.00173	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—adrenal gland cancer	0.00157	0.00173	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00154	0.0017	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TERT—adrenal gland cancer	0.00152	0.00168	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—adrenal gland cancer	0.00151	0.00167	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—adrenal gland cancer	0.00151	0.00167	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—adrenal gland cancer	0.0015	0.00166	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.0015	0.00165	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00147	0.00163	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00147	0.00162	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00144	0.00159	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00141	0.00156	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00141	0.00156	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00137	0.00151	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00136	0.0015	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00136	0.0015	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BAD—adrenal gland cancer	0.00132	0.00146	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.00122	0.00135	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—adrenal gland cancer	0.00122	0.00135	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—adrenal gland cancer	0.00122	0.00134	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.0012	0.00133	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.0012	0.00133	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00119	0.00132	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.00117	0.00129	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—adrenal gland cancer	0.00116	0.00129	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00113	0.00125	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—adrenal gland cancer	0.00112	0.00124	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—adrenal gland cancer	0.00112	0.00124	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—adrenal gland cancer	0.00108	0.00119	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—adrenal gland cancer	0.00108	0.00119	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SPARC—adrenal gland cancer	0.00108	0.00119	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.00106	0.00117	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SDHB—adrenal gland cancer	0.00105	0.00116	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000957	0.00106	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.000909	0.001	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000869	0.00096	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000827	0.000914	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000788	0.000871	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000788	0.000871	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000787	0.000869	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000771	0.000852	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.000758	0.000838	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000743	0.000821	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNAS—adrenal gland cancer	0.000737	0.000814	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000689	0.000761	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SDHD—adrenal gland cancer	0.000677	0.000749	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM1—adrenal gland cancer	0.000677	0.000749	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000638	0.000705	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000635	0.000701	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000626	0.000691	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000588	0.000649	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000578	0.000639	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000568	0.000627	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MED12—adrenal gland cancer	0.000505	0.000558	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000452	0.000499	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000429	0.000474	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRKACA—adrenal gland cancer	0.000368	0.000407	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000366	0.000404	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000366	0.000404	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00036	0.000398	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000347	0.000384	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000341	0.000377	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNAS—adrenal gland cancer	0.000299	0.00033	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—adrenal gland cancer	0.000293	0.000324	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000273	0.000301	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—adrenal gland cancer	0.000235	0.00026	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000234	0.000259	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—adrenal gland cancer	0.000201	0.000222	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000199	0.00022	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000187	0.000206	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000161	0.000178	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—adrenal gland cancer	0.00016	0.000177	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000158	0.000175	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000109	0.00012	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.66e-05	9.57e-05	CbGpPWpGaD
